SEATTLE — Providers treating people with type 2 diabetes should take a complication-centric approach for determining first-line pharmacotherapy, according to a consensus statement. An update to AACE’s Comprehensive Type 2 Diabetes Management Algorithm was published in Endocrine Practice and discussed during a plenary talk at the AACE Annual Scientific and Clinical Conference. The